MedTrace Logo

CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation

NCT00422435 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2008-10-24

No results posted yet for this study

Summary

This study is designed to evaluate the performance and safety of a new catheter system.

Conditions

  • Coronary Disease

Interventions

DEVICE

CoStar™ Paclitaxel-Eluting Coronary Stent with SRX catheter

Paclitaxel-Eluting Coronary Stent

Sponsors & Collaborators

  • Conor Medsystems

    lead INDUSTRY

Principal Investigators

  • Christophe Dubois, M.D. · UH Gasthuisberg

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-05-31
Completion
2008-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00422435 on ClinicalTrials.gov